Justin Loizos
The Just MS (Multiple Sclerosis) Show
A podcast about multiple sclerosis hosted by Justin Loizos. Each episode will explore the world of MS. This will either be done through interviews with MS stakeholders or with Justin providing information about the illness. Thank you for listening.
Be sure to visit the podcast's website and support the creator: Www.justmultiplesclerosis.com
Author
Justin Loizos
Category
Podcast website
Latest episode
Nov 4, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
When MS Isn’t MS, a New Tablet’s Trial Results & Earlier Clues Just MS News 04.11.2026 17:31
Send us Fan Mail Nearly 20 years with an MS diagnosis—then a different answer. An experimental MS tablet raises questions about effectiveness and safety. And researchers investigate whether AI could help recognize MS earlier. In this edition of Just MS News, covering October 27–November 2, 2026, Justin Loizos looks at three stories about getting the diagnosis right, understanding treatment evidenc...
Christina Applegate’s MS Diagnosis Questions, Remibrutinib Results & CAR-T Safety | Just MS News 27.10.2026 17:41
Send us Fan Mail Description This week on Just MS News: Christina Applegate’s reported MS misdiagnosis, detailed Phase 3 results for remibrutinib, and early CAR-T findings that raise serious safety questions. Join Justin Loizos for the week of October 20–26, 2026, as we explore what these stories mean for people living with multiple sclerosis—and what remains uncertain. In this episode: • Christin...
New Clues to MS Damage, GLP-1 Drug Research & Progression Beyond Relapses | Just MS News 20.10.2026 17:11
Send us Fan Mail How can we better understand MS damage—and recognise progression when relapses aren’t happening? This week on Just MS News, Justin Loizos explores new research into MS damage, GLP-1 drugs and progression beyond relapses, alongside more research and community headlines. TOP THREE STORIES New clues to MS damage Research examining the lining of the brain’s fluid-filled spaces and its...
Ocrevus: 10-Year Results, Myelin Repair Funding & MSToronto2026 | Just MS News 13.10.2026 13:05
Send us Fan Mail What can long-term treatment research tell us about living with MS—and what will it take to move myelin repair research forward? This week on Just MS News, Justin Loizos explores three stories connecting treatment, research funding and the MS community. OCREVUS: TEN-YEAR FINDINGS We examine the ten-year OPERA follow-up published in JAMA Neurology, what it suggests about starting o...
FDA Reviews Fenebrutinib, Remyelination Trial Begins & New MS Inflammation Target | Just MS News 06.10.2026 14:50
Send us Fan Mail This week in Just MS News, we cover three important developments across the MS research pipeline. The FDA has begun Priority Review of fenebrutinib for both relapsing MS and primary progressive MS, following three major Phase III trials. We also revisit PRO-1562, a remyelination therapy we’ve followed before, as it moves from preclinical research into its first Phase 1/2a human st...
Alpha-Lipoic Acid Advances | EBV Before Relapse, Ocrevus & CAR-T - Just MS News 22.09.2026 15:32
Send us Fan Mail This week in Just MS News : Alpha-lipoic acid has passed an important interim checkpoint in the phase 3 OCTOPUS trial for progressive MS , while metformin will not continue. This does not yet prove ALA slows disability progression, but it has shown enough potential to keep testing. A new Nature Medicine study also found EBV-related immune changes appearing roughly 30–90 days befor...
Early MS Treatment, Late-Onset Progression & What Drives MS Fatigue | Just MS News 14.09.2026 17:49
Send us Fan Mail This week on Just MS News , we look at new research examining three very different parts of living with multiple sclerosis. Our lead story follows more than 500 newly diagnosed people with MS and compares early treatment strategies. B-cell-depleting therapies were linked with fewer relapses and less MRI activity — but after two years, researchers did not find a significant differe...
3 Deaths Halt CAR-T Trials | This Week in Multiple Sclerosis 07.09.2026 14:00
Send us Fan Mail This week on Just MS News , we lead with a difficult but important story: Novartis has paused eight CAR-T clinical trials after three patient deaths linked to severe immune reactions. These are not simply numbers in a clinical trial or events affecting a company's share price. They were people who entered research hoping for something better. We look at what happened, what it...
Can Walking Data Reveal MS Progression Earlier? + EBV Vaccine Research | Just MS News 25 - 31/08 2026 01.09.2026 14:40
Send us Fan Mail This week on Just MS News , we break down some of the most important multiple sclerosis research and developments from August 25–31, 2026. Our top stories: 🚶 Everyday Walking Data & MS Progression Researchers are looking at whether real-world walking measurements could help reveal MS progression earlier. Source: Multiple Sclerosis Journal 🦠 EBV, MS & the Push for a Vacci...
Could Your Eyes Reveal MS Progression? + The Race to Repair Myelin | Just MS News 18 - 24-08-2026 24.08.2026 14:36
Send us Fan Mail This week on Just MS News, we’re focusing on two important areas of multiple sclerosis research: understanding progression and repairing damage. 👁️ Could your eyes reveal clues about MS progression? Researchers are investigating whether measurements of retinal layers using OCT — optical coherence tomography — could help identify people at greater risk of future cognitive progressi...
Big Week in MS Research: CAR-T, New Diagnosis Criteria & Remyelination | Just MS News 11th - 17th 17.08.2026 13:59
Send us Fan Mail This week on Just MS News , we look at four developments in multiple sclerosis research and diagnosis — including an important FDA regulatory milestone for CAR-T therapy in progressive MS. This week: 🔶 CAR-T for non-active SPMS The FDA has granted RMAT designation to miv-cel, an experimental CD19 CAR-T therapy being studied in non-active secondary progressive MS. The designation...
Hidden MS Progression, NAC, Exercise & Christina Applegate Update | Just MS News 04/08 - 10 /08 2026 11.08.2026 18:25
Send us Fan Mail This week on Just MS News, we take a closer look at three important stories from the multiple sclerosis community. First, new research in JAMA Neurology strengthens the evidence around GFAP, a blood biomarker that may help researchers track progression independent of relapse activity, or PIRA. The study included more than 2,300 people with MS and over 18,000 blood measurements. Th...
Just MS News: Mini Brains and Myelin Repair, July 28th - Aug 3rd 03.08.2026 18:29
Send us Fan Mail This Week on Just MS News This week, we look at three important stories affecting the MS community. Researchers in Australia are using lab grown “mini brains” to investigate how damaged myelin might one day be repaired. Sheffield Teaching Hospitals has also treated its first MS participant with experimental CAR T cell therapy, an approach researchers have been watching for years....
REMYELINATION RESEARCH, FAMPRIDINE ACCESS & MS MORTALITY DISPARITIES | JUST MS NEWS 20/07 - 27/07/2026 27.07.2026 26:16
Send us Fan Mail This week on Just MS News, we lead with encouraging—but still early remyelination research. Scientists have identified an experimental small molecule that promoted oligodendrocyte development and remyelination in preclinical models. We explain how this candidate differs from PTD802, the remyelination therapy we recently covered as it prepared to enter human testing. We also look a...
New EBV Clues, Early Pediatric MS Treatment Stopping DMTs and an MS Wedding | Just MS News July 13th - 19th 2026 20.07.2026 20:20
Send us Fan Mail This week on Just MS News, we examine new research that may help clarify how Epstein–Barr virus fits into the immune process behind multiple sclerosis. We also look at evidence supporting earlier high-efficacy treatment for pediatric-onset MS, the DOT-MS trial on stopping treatment after years of stable disease, virtual-reality rehabilitation for cognitive symptoms, and a Colorado...
Just MS News: AI Finds Hidden MS Lesions and Rituximab Faces Ocrevus Head-to-Head, 06/07- 12/07/2026 13.07.2026 37:27
Send us Fan Mail This week on the Just MS Show, we look at five important multiple sclerosis stories. Researchers used artificial intelligence to identify gray matter lesions that can be difficult to see on standard MRI scans. We also examine a head-to-head trial comparing rituximab with Ocrevus in newly diagnosed relapsing MS. Other stories include the completion of enrollment in a nasal foraluma...
Just MS News, Week of June 29– July 06, 2026: Two Stories, One Study: Why MS Progression Can Look So Different 06.07.2026 17:30
Send us Fan Mail This week’s Just MS News starts with two stories from the same MS brain-donor study, looking at why progression can differ so much from person to person. We also cover MS Copilot and digital disability monitoring, research into fat-filled immune cells called foamy microglia, an experimental brain implant for speech loss, and Spain’s “Get Wet for MS” campaign supporting neurorehabi...
Just MS News, June 22 - 28: Remyelination Trial, SPMS Approval, Fatigue, Cognition, and Balance 29.06.2026 12:00
Send us Fan Mail This week on Just MS News, we reviewed 139 MS-related articles from June 22–28, 2026, and narrowed them down to the stories most worth your time. The lead story this week is early, but meaningful: PTD802, an oral remyelination therapy, has been cleared for its first human trial. It is not an approved treatment, and it is not a cure. But for people living with MS, research focused...
Just MS News, Week of June 15–21, 2026: Hidden Symptoms, Brain Atrophy & MS Research 22.06.2026 16:10
Send us Fan Mail This week on Just MS News , we look at nine MS stories from the week of June 15–21, 2026. Topics include hidden cognitive symptoms, brain atrophy research, cognitive testing and daily life, accessible travel, progression independent of relapse activity, PFAS exposure, vaccine safety, mobility technology, and early repair-focused stem cell research. Just MS News is built to help th...
Milestone on the Parallel Bars: Progress in My MS Journey 25.05.2026 7:24
Send us Fan Mail In this episode of The Just MS Show, I share a recent visit with my physio doctor that became a meaningful milestone in my multiple sclerosis journey. After years of challenges, setbacks, and rebuilding following my back injury, hearing such a positive reaction from someone who has closely followed my condition for over a decade meant a lot to me. I talk about the progress I’ve ma...
The Rare Good MS News Report: My DXA Surprise 09.11.2025 17:32
Send us Fan Mail In this episode of The Just MS Show, I share two moments that define the push-pull of life with MS: a recent fall (my “fish out of water” moment) and the unexpectedly positive results from my annual DXA (DEXA) bone density scan, which I do because of prior high-dose steroid treatments. I walk through the scan process, the follow-up with my doctor, and why this result felt rare—and...
Accident, Accessibility, and Unexpected Good News 08.10.2025 17:42
Send us Fan Mail In this episode, I catch up on the past month or two — from a tough fall that sent me to the ER (thankfully, nothing broken) to a string of lessons in accessibility and recovery. I talk about attending recent Leafs and Jays games, comparing the accessibility setups and how each outing comes with its own cost-and-recovery balance. I also touch on an expensive physio assessment that...
Stem Cell Breakthrough Without Chemo. A.I. Episode 25.07.2025 8:42
Send us Fan Mail A.I. Episode: Stem Cell Breakthrough Without Chemo In this special AI-hosted edition of The Just MS Show, we dive into a groundbreaking medical breakthrough: a novel stem cell transplant method that eliminates the need for toxic chemotherapy or radiation. Learn how this antibody-based technique, trialed at Stanford University, could revolutionize treatment not only for Fanconi ana...
Workout to Wheelchair - Why Trying to Get Stronger Made Me Weaker 23.07.2025 16:06
Send us Fan Mail 🎙️ Workout to Wheelchair Why Trying to Get Stronger Made Me Weaker In this raw and personal episode of The Just MS Show, I share how pushing my body too far — even with the best intentions — led to injuries that rapidly worsened my Multiple Sclerosis (MS). From breaking my foot and rib, to temporary blindness, to a devastating lower back injury during lockdown workouts, each momen...
Staying Fit with Multiple Sclerosis: One Year of Adaptive Fitness & MS Self-Care 16.07.2025 24:18
Send us Fan Mail In this episode of The Just MS Show , host Justin Loizos shares his personal journey of maintaining a consistent fitness routine while living with Multiple Sclerosis (MS) . From using adaptive gym equipment like the NuStep machine to performing aquatic therapy in an accessible pool, Justin highlights how movement and exercise help him manage symptoms and improve overall well-being...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.